Dabigatran Toxicity

Dabigatran Toxicity is an anticoagulant toxicity characterized by pathological bleeding or coagulopathy resulting specifically from the exaggerated pharmacological inhibition of thrombin mediated by the direct oral anticoagulant dabigatran.

66

Publications

3.9K

Citations

416

Authors

203

Institutions

Publications per year

2017–2026

17

Authors

416

  1. MD
    Michael D. Ezekowitz

    Population Health Research Institute, Canada

    6 publications · 1.1K citations

    6

    h-index

  2. JF
    Jeffrey Friedman

    Boehringer Ingelheim (Germany), Germany

    5 publications · 273 citations

    5

    h-index

  3. WG
    William G. Stevenson

    Brigham and Women's Hospital, United States

    5 publications · 1.4K citations

    4

    h-index

  4. JE
    James E. Lowe

    Duke Medical Center, United States

    5 publications · 1.4K citations

    4

    h-index

  5. CK
    Clive Kearon

    McMaster University, Canada

    4 publications · 85 citations

    4

    h-index

1–5 of 416

Venues

  1. Blood

    7 publications · 729 citations

    7

    h-index

  2. Thrombosis Research

    3 publications · 81 citations

    3

    h-index

  3. Journal of Cardiology

    3 publications · 68 citations

    3

    h-index

  4. Journal of Thrombosis and Thrombolysis

    3 publications · 81 citations

    3

    h-index

  5. American Heart Journal

    AHJ · 2 publications · 219 citations

    2

    h-index

1–5